Racism and Its Effect on Cannabis Research

Scientific research depends on legitimacy. We challenge legitimacy by questioning methods, researchers, funders, bias, and myriad other means. Popular culture has created a cottage industry on the dangers of the brilliant but arrogant mad scientist and the incompetent amateur, who stagger into unknown and dangerous waters. The stories rarely end well, and they are played as cautionary morality plays. From Frankenstein*^,1 to Stranger Things,^†,2 the consistent message is that humans should not try to become gods.

Cannabis falls into a different category. In 1850, cannabis, a plant with a history of medical usage for thousands of years, was listed for the first time in the United States Pharmacopeia, third Ed., as “Extractum Cannabis or Extract of Hemp.”³ The listing continued until 1942, 5 years after the passage of the Marihuana Tax Act (MTA) of 1937.⁴ The 1937 Act began a period of federal prohibition, a policy that continues today under the Controlled Substance Act (CSA),⁵ which classifies cannabis as a Schedule I drug with a high potential for abuse and no accepted medical use, like heroin, and more dangerous than cocaine or methamphetamine.

Neither the 1937 MTA nor its successor, the 1970 CSA, was founded on a fact-based inquiry, serious policy considerations, or even morality. Historians continue to debate whether the anticannabis campaign leading to the passage of the MTA was for the economic benefit of William Randolph Hearst, the Dupont Corporation, and Andrew Mellon, one of Dupont's investors.^6,7,‡,§ Even putting economic interests aside, Hearst and Mellon were at the center of a vicious anticannabis campaign based on racism, sensationalism, and social control of racial minorities. Racism and sensationalism are strong allegations, but consider the roles of Hearst, Mellon, and Harry Anslinger.

William Randolph Hearst controlled a journalism empire unheard of at the time⁸ and dwarfing any modern media conglomerate.^** In 1923, a Hearst paper reported that “Marihuana is a short cut to the insane asylum. Smoke marihuana cigarettes for a month and what was once your brain will be nothing but a storehouse for horrid specters.”⁹ In 1928, a Hearst paper reported that “marijuana was known in India as the ‘murder drug,’ it was common for a man to ‘catch up a knife and run through the streets, hacking and killing every one he [encountered].’”¹⁰ In one of the most bizarre claims, the article claimed one could grow enough cannabis in a window box to “drive the whole population of the United States stark, raving mad.”¹⁰

Hearst newspapers published a steady stream of anticannabis stories, but they were not alone. As early as 1913, The Salt Lake Tribune, under the headline, Evil Mexican Plants that Drive You Insane, reported that “marijuana make(s) the smoker wilder than a wild beast”¹¹ and provided anecdotal evidence of average people who became murderers after smoking cannabis.

In 1930, Harry Anslinger, became the first director of the Federal Bureau of Narcotics.¹² Ansliger was appointed to the position by Secretary of the Treasury Andrew Mellon, his wife's uncle.¹³ Ansliger, an avid supporter of prohibition, had minimized the dangers of cannabis before his appointment. Once appointed, he began a campaign based on race and violence. Anslinger did not hide his prejudice, with comments like, “There are 100,000 total marijuana smokers in the US, and most are Negroes, Hispanics, Filipinos, and entertainers. Their Satanic music, jazz and swing, results from marijuana use. This marijuana causes white women to seek sexual relations with Negroes, entertainers, and others.”¹⁴ Anslinger helped popularize the use of “marijuana” instead of the more common “cannabis,” to tie the drug to anti-Mexican prejudice.^15,16 Anslinger's themes were replicated in the movie Reefer Madness¹⁷: cannabis turns men to violence and women to sexual promiscuity.^††

Later, the Nixon administration was more subtle, but no less cynical, in enacting the CSA. Many people think of modern cannabis policy as starting with the CSA, but the Act was in basic principle a continuation of the MTA of 1937,⁴ which had the intent of prohibiting cannabis on a federal level. When the MTA was held to be unconstitutional in 1969,¹⁸ the Nixon administration formed a commission under the chairmanship of Raymond Shafer, a former Republican Governor of Pennsylvania.¹⁹ Nixon saw the commission as a means to establish the dangers of cannabis. To Nixon, the Shafer Commission was the opposite of legitimate scientific inquiry. It was a hit job and, as we learned later through the Nixon tapes,^20,21 the hit was directed at African Americans and the antiwar movement, two groups Nixon despised.

John Erlichman, a senior advisor to Nixon, was later quoted as saying “We knew we couldn't make it illegal to be either against the war or black, but by getting the public to associate the hippies with marijuana and blacks with heroin, and then criminalizing both heavily, we could disrupt those communities. We could arrest their leaders, raid their homes, break up their meetings, and vilify them night after night on the evening news. Did we know we were lying about the drugs? Of course we did.”²¹ Ray Shafer did not get with the program. The commission concluded that cannabis was not as dangerous as perceived, and recommended decriminalization.^19,22 The Administration and Congress ignored the recommendation and moved forward with the CSA.

The subsequent War on Drugs may have put hippies and the antiwar movement in a bad light, but, as shown by Michelle Alexander in The New Jim Crow,²³ it was African American young men who paid the price by way of massive arrests. The conservative Cato Foundation and liberal Center for American Progress both agree that Nixon's War on Drugs, which was enforced by subsequent administrations, was an expensive failure, resulting in a period of ∼50 years of a federal policy based on a false premise and a conscious avoidance of evidence-based research.^24,25

The consequences of federal policy include the Schedule I listing,^26–28 a requirement to use limited and inadequate federally approved cannabis from the University of Mississippi for research,^{‡‡,§§,***} a federal bureaucracy tied to antiquated policies, and limited funding. As states liberalize cannabis use, state actors continue to act in fear of federal reprisals. State universities, including some of the greatest research facilities in the world, want to foster research, but are justifiably risk averse to any activity that may place federal funding in jeopardy.^†††

We are not very good at admitting past mistakes, especially on issues of race, and that has consequences. When federal drug policy is to “Just Say No,”^{‡‡‡,§§§} there is little room for discussion. When the Attorney General of the United States comments that good people do not smoke cannabis,^31,32 which he views as a gateway to the opium crisis and heroin use,^{****,††††} he quashes a rational discussion and signals that any research will be based on curtailing cannabis, not exploring its medical and social potential. Nancy Reagan and William Sessions are gone, but the policy lives on.

Cannabis laws are evolving quickly and rescheduling may occur in the near future. Until then, research will be inhibited, with a virtual lock on some of the most promising research. To move forward, we need to understand our own history, and the false premise on which we have based this misguided policy. We need to treat the cannabis policy started in 1937 the same way we treat segregated schools,^{‡‡‡‡,33,34} miscegenation,^§§§§ and other race-based policy. Our inquiry needs to start with an acknowledgment of the history of racial discrimination in our drug policy and move toward serious evidence-based research. If we fail to do so, we will remain the willing victims of our own racist history.

Abbreviations Used

CSA

Controlled Substance Act

DEA

Drug Enforcement Administration

MTA

Marihuana Tax Act

UCOP

University of California Office of the President

Author Disclosure Statement

No competing financial interests exist.

Funding Information

No funding was received for this article.

Cite this article as: Solomon R (2020) Racism and its effect on cannabis research, Cannabis and Cannabinoid Research 5:1, 2–5, DOI: 10.1089/can.2019.0063.